Closing Symposium of the TIGER Project (News)
https://www.swisstph.ch/en/news/news-detail/news/closing-symposium-of-the-tiger-project
tiger mosquito," said Philipp Hübner, Head of the Cantonal Laboratory of Basel-Stadt during his opening speech at the symposium. “Cross-border cooperation is working well in the fight against the tiger
Largest Clinical Trial in Africa to Treat COVID-19 Cases is Launched in 13 Countries (News)
https://www.swisstph.ch/en/news/news-detail/news/largest-clinical-trial-in-africa-to-treat-covid-19-cases-is-launched-in-13-countries
training, we aim to support our partners in upholding the highest quality standards." ANTICOV is an open-label, randomised, comparative, ‘adaptive platform trial’ that will test the safety and efficacy of
Achieving Universal Health Coverage in Chad (News)
https://www.swisstph.ch/en/news/news-detail/news/achieving-universal-health-coverage-in-chad
UHC," said Boukari Ouedraogo, coordinator of PADS at Swiss TPH. "Quality and access are the door-openers for engaging communities, finding community champions for health, and putting greater equity into
What makes health systems resilient? A qualitative analysis of the perspectives of Swiss NGOs (Publications)
endeavour and a result of many stakeholders' consistent and targeted investments. These investments open up new opportunities to seek innovative solutions and to keep diverse actors in global health accountable
Human African Tryponosomiasis | SwissTPH (Page)
https://www.swisstph.ch/en/topics/sleeping-sickness
patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense : a multicentre, open-label, single-arm, phase 2/3 trial. Lancet Infect Dis . 2023;23(4):463-470. DOI: 10.1016/S1473-30 [...] fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial. Lancet Glob Health . 2022;10(11):e1665-e1674. DOI: 10.1016/S2214-109X(22)00338-2
Work with Us | Jobs and Careers at Swiss TPH (Page)
https://www.swisstph.ch/en/about/careers
to preserve and improve global health.” Prof. Dr. Jürg Utzinger Director, Swiss TPH Open Positions at Swiss TPH Open Positions at the University of Basel Swiss TPH | Who we are Vision and Mission Diversity
MSc in Epidemiology | Study at Swiss TPH (Page)
https://www.swisstph.ch/en/study-with-us/bachelor-and-master/msc-in-epidemiology
Odermatt, Prof. Martin Röösli Contact: Pascal Gschwind (+41 61 284 83 60) Target Group: The course is open to students with a Bachelor of Science (BSc) in Biology, Human, Dental or Veterinary Medicine, Ph
Travellers' Health | Clinical Short Courses at Swiss TPH (Page)
https://www.swisstph.ch/en/study-with-us/postgraduate/travellers-health
disorders, eosinophilia), management of imported diseases. Who Should Take this Course? The course is open to medical doctors, senior nursing staff, pharmacists and other health professionals, as well as to
Axs2OH: Access to Oral Health | Swiss TPH Projects (Page)
https://www.swisstph.ch/en/projects/axs2oh
Basel Landschaft or Zurich. What does participation involve? Currently, participation in the survey is open. If you are recruited to participate, a member of the study team will make an appointment to ask you
Research and implementation lessons learned from a youth-targeted digital health randomized controlled trial (the ARMADILLO Study) (Publications)
and their implications for digital health researchers and program implementers. METHODS: This was an open, three-armed RCT. Following completion of a baseline survey, participants were randomized into the
